CastleVax Revenue and Competitors
Employee Data
- CastleVax has 7 Employees.
- CastleVax grew their employee count by -12% last year.
CastleVax's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO/CSO | Reveal Email/Phone |
2 | VP Operations | Reveal Email/Phone |
3 | Head Quality and CMC | Reveal Email/Phone |
4 | Director Clinical Operations | Reveal Email/Phone |
5 | Clinical Program Manager | Reveal Email/Phone |
CastleVax Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 48 | -9% | N/A | N/A |
#10 | $16.1M | 88 | 4% | N/A | N/A |
What Is CastleVax?
CastleVax is the proven technology that will bring safe vaccines for all humans, everywhere. Our state-of-the-art platform for producing first-in-class vaccines uses Newcastle Disease Virus (NDV) to enable rapid development of safe and highly immunogenic viral vectors that are easy to deliver and store, and can be administered via injection or intranasally. \n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less
keywords:N/A
N/A
Total Funding
7
Number of Employees
N/A
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.7M | 7 | 40% | N/A |
#2 | $0.1M | 7 | 0% | $6.1M |
#3 | $3.5M | 7 | -30% | N/A |
#4 | $1.4M | 7 | -36% | N/A |
#5 | $0.5M | 7 | N/A | N/A |